advisory

National Academies advisory: Invasive aquatic species in the Great Lakes

On May 7, a National Research Council committee will hold a meeting in Toronto to gather information on trade in the Great Lakes region and ways to eliminate further introductions of nonindigenous aquatic species into the lakes by vessels traveling the St. Lawrence Seaway. The committee's final report will comment on the strengths and weaknesses of various options and recommend those that seem mo...

advisory at Biology Products

No data found

Search advisory biology products at Google

Search advisory biology products at Yahoo

Search advisory biology products at Msn

advisory at Biology Technology

Quintessence Biosciences forms cancer therapeutic advisory board

MADISON Announced last week by President and Chief Executive Officer , the board will consist of distinguished...

GenTel Appoints Burke to its Scientific Advisory Board

MADISON, Wis. October 17, 2003. GenTel BioSurfaces, Inc., a privately held UWMadison biotechnology spin-off, announced today that it has appointed Thomas J. Burke, Ph.D., to its Scientific Advisory Board. "Tom's extensive scientific experience, as well as his demonstrated expertise in grant writing, intellectual property management, and new product development make him ideally suited to...

advisory at Medicine News

WHO lifts HongKong advisory

The World Health Organization has lifted its SARS-related travel warnings for Hong Kong and China's Guangdong province, as a possible breakthrough in the origin of the virus emerged. It is believed the epidemic originated in Guangdong, and officials praised national health authorities for controlling the outbreak in those areas. Hong Kong Chief Executive Tung Chee-Hwa welcomed the lifting...

FDA Issues Public Health Advisory on Tysabri, a New Drug for MS

The Food and Drug Administration (FDA) today issued a public health advisory to inform patients and health care // providers about the suspended marketing of Tysabri (nataluzimab) while the agency and the manufacturer evaluate two serious adverse events reported with its use. Tysabri, which received accelerated approval from FDA in November 2004, is an innovative treatment that repre...

Doctors Said – ‘Stop Pressurising NHS Advisory Bod’

The NICE (National Institute for Health and Clinical Excellence) carried out study regarding whether if new drugs and technologies are cost effective or not//....

Merck's Pain Reliever Arcoxia Rejected by US Federal Advisory Panel

An advisory panel of the United States Food and Drug Administration (FDA) has rejected pharmaceutical giant Merck's bid to market Arcoxia,// a new osteoarthritis medication following concerns that it may carry cardiovascular risks. Osteoarthritis is a joint disease that mostly affects cartilage. Cartilage is the slippery tissue that covers the ends of bones in a joint. Whil...

FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too

Anti-depressants could indeed lift one out of depression. But its potential to drive teenagers to suicide has already been recognized//. Now the U.S. Food and Drug Administration (FDA) has proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior,...

More>>

advisory at Medicine Products

No data found

Search advisory medicine products at Google

Search advisory medicine products at Yahoo

Search advisory medicine products at Msn

advisory at Medicine Technology

MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions

Data from the PROactive and CHICAGO studies of ACTOS(R)(pioglitazone HCl) will be presented in poster format at the 67thScientific Sessions of the American Diabetes Association inChicago: -- Hospitalizations for serious adverse events in high-risk type 2 diabetes patients treated with pioglitazone for 3...

FDA Announces Change of Location Notice for Upcoming Advisory Committee Meeting

ROCKVILLE, Md., April 18, 2007--Due to water damage caused byflooding over the weekend, FDA has been forced to change thelocation for the upcoming Antiviral Drugs Advisory Committeemeeting on April 24, 2007 to discuss new drug application formaraviroc 300 milligram tablets. Originally scheduled to be held atthe FDA, Center for Drug Evaluation and Research Advisory CommitteeConference Roo...

Media Advisory: ACC Updated Schedule

Schering-Plough Announces Presentation Of Phase II Trial ResultsFor Novel Oral Thrombin Receptor Antagonist At The 2007 AnnualMeeting Of The American College Of Cardiology/i2 Summit KENILWORTH, N.J., March 16, 2007 /PRNewswire-FirstCall/ --Schering-Plough Corporation announced today that results of thePhase II trial of its novel oral thrombin receptor antagonist (TRA)SCH 530348 will be pr...